Pharma services investors
7 investors that name Pharma services among their sectors are recorded here: 6 private equity firms and 1 venture capital firm. Stated investment stages run from seed to buyout. Most are headquartered in the United States (6) and the United Kingdom (1). Every fact comes from the investor’s own website and links back to the page it was read from. Coverage is incomplete and biased toward investors who publish clearly.
| Investor | Layer | Type | Stage | Headquarters |
|---|---|---|---|---|
| Ampersand Capital Partners Laboratory Products · Laboratory Services · Contract Manufacturing · Pharma Services |
Direct investor | Private equity | Growth – Buyout | Boston, United States |
| Baird Capital B2B Technology & Services · Pharma Services · Industrial Tech & Sustainability · Tech Services & Software |
Direct investor | Private equity | Growth – Buyout | London, United Kingdom |
| Biospring Management, LLC pharma services · biomanufacturing · clinical trial services · digital transformation |
Direct investor | Private equity | Growth – Buyout | New York, United States |
| Grant Avenue Capital LLC Healthcare Services · Pharma Services · Medtech · Healthcare IT |
Direct investor | Private equity | Growth – Buyout | New York, United States |
| Healthquest Capital Management, L.P. healthcare services · healthcare IT · medical devices · diagnostics |
Direct investor | Private equity | Growth | United States |
| Kineticos Life Sciences Management LLC life sciences · pharma services · tools · equipment |
Direct + LP | Venture capital | Seed – Growth | Raleigh, United States |
| QHP Capital, L.P. healthcare · life sciences · pharma services · tech-enabled services |
Direct investor | Private equity | Growth – Buyout | Raleigh, United States |